Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-16 07:00 |
Valneva Reports Full Year 2022 Revenue and Cash, Provides First 2023 Guidance
|
English | 217.6 KB | ||
| 2023-02-14 07:00 |
Valneva Completes Enrollment for Adolescent Phase 3 Trial of Single-Shot Chikun…
|
English | 180.0 KB | ||
| 2023-02-14 07:00 |
Valneva finalise le recrutement pour l’essai de Phase 3 chez les adolescents de…
|
French | 223.1 KB | ||
| 2023-02-03 18:00 |
VALNEVA Declaration of shares and voting rights - January 31, 2023
|
English | 47.2 KB | ||
| 2023-02-03 18:00 |
VALNEVA Déclaration d’actions et de droits de vote - 31 janvier 2023
|
French | 157.4 KB | ||
| 2023-01-05 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 décembre 2022
|
French | 159.4 KB | ||
| 2023-01-05 18:00 |
VALNEVA - Declaration of shares and voting rights: December 31, 2022
|
English | 101.9 KB | ||
| 2022-12-30 18:30 |
Valneva annonce de nouvelles données de rappel hétérologue pour son vaccin inac…
|
French | 180.7 KB | ||
| 2022-12-30 18:30 |
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 …
|
English | 174.1 KB | ||
| 2022-12-23 07:00 |
Valneva achève la soumission du dossier de demande d’autorisation de mise sur l…
|
French | 217.5 KB | ||
| 2022-12-23 07:00 |
Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Va…
|
English | 160.8 KB | ||
| 2022-12-21 17:45 |
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Confere…
|
French | 106.5 KB | ||
| 2022-12-21 17:45 |
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conferen…
|
English | 106.1 KB | ||
| 2022-12-06 07:00 |
Valneva confirme sa journée investisseurs à New York
|
French | 201.3 KB | ||
| 2022-12-06 07:00 |
Valneva Hosts Investor Day in New York City
|
English | 205.5 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
